David Cragg - 02 Mar 2022 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
03 Mar 2022, 15:40:06 UTC
Prior SEC filing
01 Mar 2022
Next SEC filing
08 Mar 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
By: Robert Wong For: David Cragg

Key filing fact

David Cragg filed Form 4 for CYTOKINETICS INC (CYTK) on 03 Mar 2022.

Key facts

  • This page summarizes David Cragg's Form 4 filing for CYTOKINETICS INC (CYTK).
  • 4 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 03 Mar 2022, 15:40.

Change

  • Previous filing in this sequence was filed on 01 Mar 2022.
  • Current net transaction value: +$1,751,375.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CYTK transaction

Common Stock

Tax liability

Transaction value
$130,125
Shares
-3,458
Change %
-2.4%
Price
$37.63
Shares after
138,632
Date
02 Mar 2022
Ownership
Direct
Footnotes
F1
CYTK transaction

Common Stock

Award

Transaction value
$0
Shares
+20,000
Change %
+14%
Price
$0.000000
Shares after
158,632
Date
02 Mar 2022
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CYTK transaction Derivative

Incentive Stock Option (right to buy)

Award

Transaction value
$145,327
Shares
+3,862
Change %
Price
$37.63
Shares after
3,862
Date
02 Mar 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,862
Exercise price
$37.63
Footnotes
F3
CYTK transaction Derivative

Non-Qualified Stock Option (right to buy)

Award

Transaction value
$1,736,173
Shares
+46,138
Change %
Price
$37.63
Shares after
46,138
Date
02 Mar 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
46,138
Exercise price
$37.63
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units vested on 03/02/2022 and does not represent a sale by the reporting person.

Footnote F2

Comprised of restricted stock units that will vest over 3 years, with 40% vesting on the 1-year anniversary of the grant, an additional 40% vesting on the 2-year anniversary of the grant, and the final 20% vesting on the 3-year anniversary of the grant.

Footnote F3

This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .